This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) rose 1.71% to $159.79 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.36% to 4,003.58 and the Dow Jones Industrial Average rising 1.18% to 34,098.10. This was the stock's fourth consecutive day of gains. AbbVie Inc. closed $16.12 short of its 52-week high ($175.91), which the company achieved on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Pfizer Inc. (PFE) rose 1.87% to $49.08, Eli Lilly & Co. (LLY) fell 0.08% to $360.88, and AstraZeneca PLC ADR (AZN.LN) rose 0.87% to $66.00. Trading volume (5.3 M) remained 529,742 below its 50-day average volume of 5.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 22, 2022.
(END) Dow Jones Newswires
November 22, 2022 16:33 ET (21:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.